Placeboresponse und Placeboeffekt: Mechanismen, Mediatoren, Moderatoren

Lernziele

den grundsätzlichen Unterschied zwischen der Placeboantwort (Placeboresponse) und dem Placeboeffekt verstehen den Unterschied zwischen Lernen und Erwartung als Mechanismen des individuellen Placeboeffektes verstehen verstehen, dass verschiedene psychosoziale und biologische Mediatoren den Placeboeffekt vermitteln verstehen, dass Moderatoren auf den Placeboeffekt Einfluss nehmen die unterschiedlichen Konsequenzen verstehen, die Placeboeffekte für die experimentelle Forschung, für klinische Medikamentenprüfungen und für den klinischen Alltag haben

Literatur

• 1 Enck P, Benedetti F, Schedlowski M. New insights into the placebo and nocebo responses.  Neuron. 2008;  59 195-206
• 2 Moseley J B, O'Malley K, Petersen N J. et al . A controlled trial of arthroscopic surgery for osteoarthritis of the knee.  N Engl J Med. 2002;  347 81-88
• 3 Enck P, Klosterhalfen S, Zipfel S. Acupuncture, psyche and the placebo response.  Auton Neurosci. 2010;  157 68-73
• 4 Kaptchuk T J, Stason W B, Davis R B. et al . Sham device v inert pill: randomised controlled trial of two placebo treatments.  BMJ. 2006;  332 391-397
• 5 Khan A, Bomminayuni E P, Bhat A. et al . Are the colors and shapes of current psychotropics designed to maximize the placebo response?.  Psychopharmacology (Berl). 2010;  211 113-122
• 6 Hróbjartsson A, Gøtzsche P C. Placebo interventions for all clinical conditions.  Cochrane Database Syst Rev 2010;  (1) CD003974
• 7 Chey W D, Chey W Y, Heath A T. et al . Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome.  Am J Gastroenterol. 2004;  99 2185-2203
• 8 Klinger R, Soost S, Flor H. et al . Classical conditioning and expectancy in placebo hypoalgesia: a randomized controlled study in patients with atopic dermatitis and persons with healthy skin.  Pain. 2007;  128 31-39
• 9 Vits S, Cesko E, Enck P. et al . Behavioural conditioning as the mediator of placebo responses in the immune system.  Philos Trans R Soc Lond B Biol Sci. 2011;  366 1799-1807
• 10 Klosterhalfen S, Rüttgers A, Krumrey E. et al . Pavlovian conditioning of taste aversion using a motion sickness paradigm.  Psychosom Med. 2000;  62 671-677
• 11 Pollo A, Carlino E, Benedetti F. The top-down influence of ergogenic placebos on muscle work and fatigue.  Eur J Neurosci. 2008;  28 379-388
• 12 Kunz M, Rainville P, Lautenbacher S. Operant conditioning of facial displays of pain.  Psychosom Med. 2011;  73 422-431
• 13 Colloca L, Benedetti F. Placebo analgesia induced by social observational learning.  Pain. 2009;  144 28-34
• 14 Tracey I. Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans.  Nat Med. 2010;  16 1277-1283
• 15 Bingel U, Wanigasekera V, Wiech K. et al . The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil.  Sci Transl Med. 2011;  3 70ra14
• 16 Benedetti F, Pollo A, Lopiano L. et al . Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo / nocebo responses.  J Neurosci. 2003;  23 4315-4323
• 17 Moerman D E, Jonas W B. Deconstructing the placebo effect and finding the meaning response.  Ann Intern Med. 2002;  136 471-476
• 18 Allan L G, Siegel S. A signal detection theory analysis of the placebo effect.  Eval Health Prof. 2002;  25 410-420
• 19 Miller F G, Colloca L. Semiotics and the placebo effect.  Perspect Biol Med. 2010;  53 509-516
• 20 Colloca L, Benedetti F. How prior experience shapes placebo analgesia.  Pain. 2006;  124 126-133
• 21 Stockhorst U, Wiener J A, Klosterhalfen S. et al . Effects of overshadowing on conditioned nausea in cancer patients: an experimental study.  Physiol Behav. 1998;  64 743-753
• 22 Rief W, Nestoriuc Y, Lilienfeld-Toal A von. et al . Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis.  Drug Saf. 2009;  32 1041-1056
• 23 Amanzio M, Corazzini L L, Vase L. et al . A systematic review of adverse events in placebo groups of anti-migraine clinical trials.  Pain. 2009;  146 261-269
• 24 Häuser W, Bartram C, Bartram-Wunn E. et al . Systematic review: Adverse events attributable to nocebo in randomised controlled drug trials in fibromyalgia syndrome and painful diabetic peripheral neuropathy.  Clin J Pain. 2011;  152 1709-1717
• 25 Kaptchuk T J, Friedlander E, Kelley J M. et al . Placebos without deception: a randomized controlled trial in irritable bowel syndrome.  PLoS One. 2010;  5 e15591
• 26 Su C, Lichtenstein G R, Krok K. et al . A meta-analysis of the placebo response rates of remission and response in clinical trials of active Crohn’s disease.  Gastroenterology. 2004;  126 1257-1269
• 27 Kaptchuk T J, Kelley J M, Conboy L A. et al . Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome.  BMJ. 2008;  336 999-1003
• 28 Kelley J M, Lembo A J, Ablon J S. et al . Patient and practitioner influences on the placebo effect in irritable bowel syndrome.  Psychosom Med. 2009;  71 789-797
• 29 Levine J D, Gordon N C, Fields H L. The mechanism of placebo analgesia.  Lancet. 1978;  2 654-657
• 30 Finniss D G, Kaptchuk T J, Miller F. et al . Placebo effects: biological, clinical and ethical advances.  Lancet. 2010;  375 686-695
• 31 Enck P, Klosterhalfen S. The story of O – Is oxytocin the mediator of the placebo response?.  Neurogastroenterol Motil. 2009;  21 347-350
• 32 Furmark T, Appel L, Henningsson S. et al . A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety.  J Neurosci. 2008;  28 13 066-13 074
• 33 Leuchter A F, McCracken J T, Hunter A M. et al . Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder.  J Clin Psychopharmacol. 2009;  29 372-377
• 34 Kaptchuk T J, Kelley J M, Deykin A. et al . Do „placebo responders“ exist?.  Contemp Clin Trials. 2008;  29 587-595
• 35 Geers A L, Helfer S G, Kosbab K. et al . Reconsidering the role of personality in placebo effects: dispositional optimism, situational expectations, and the placebo response.  J Psychosom Res. 2005;  58 121-127
• 36 Weimer K, Enck P, Klosterhalfen S. Geschlechtseffekte bei der Placeboresponse.  Z Med Psychol. 19;  2010 146-153
• 37 Klosterhalfen S, Kellermann S, Braun S. et al . Gender and the nocebo response following conditioning and expectancy.  J Psychosom Res. 2009;  66 323-328
• 38 Parellada M, Moreno C, Moreno M. et al . Placebo effect in child and adolescent psychiatric trials.  Eur Neuropsychopharmacol. 2012;  [im Druck]
• 39 Rutherford B R, Sneed J R, Tandler J M. et al . Deconstructing pediatric depression trials: an analysis of the effects of expectancy and therapeutic contact.  J Am Acad Child Adolesc Psychiatry. 2011;  50 782-795
• 40 Enck P, Klosterhalfen S, Zipfel S. Novel study designs to investigate the placebo response.  MC Med Res Methodol. 2011;  11 90
• 41 Enck P, Klosterhalfen S, Weimer K. et al . The placebo response in clinical trials: more questions than answers.  Philos Trans R Soc Lond B Biol Sci. 2011;  366 1889-1895
• 42 Petrovic P, Kalso E, Petersson K M. et al . A prefrontal non-opioid mechanism in placebo analgesia.  Pain. 2010;  150 59-65
• 43 Rief W, Bingel U, Schedlowski M. et al . Mechanisms involved in placebo and nocebo responses and implications for drug trials.  Clin Pharmacol Ther. 90;  2011 722-726
• 44 Vase L, Riley 3rd J L, Price D D. A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia.  Pain. 2002;  99 443-452
• 45 Hegerl U, Mergl R. The clinical significance of antidepressant treatment effects cannot be derived from placebo-verum response differences.  J Psychopharmacol. 2010;  24 445-448
• 46 Fässler M, Meissner K, Schneider A. et al . Frequency and circumstances of placebo use in clinical practice – a systematic review of empirical studies.  BMC Medicine. 2010;  8 15